ADX-629
Sponsors
Aldeyra Therapeutics, Inc., University of Nebraska
Conditions
Alcohol HepatitisAtopic AsthmaChronic CoughCovid19Ethanol IntoxicationNephrotic SyndromePlaque PsoriasisSjogren-Larsson Syndrome
Phase 1
Phase 2
A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC)
CompletedNCT04728711
Start: 2021-01-09End: 2022-01-18Updated: 2025-02-17
A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19.
CompletedNCT04847544
Start: 2021-03-31End: 2021-10-15Updated: 2025-02-17
A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis
CompletedNCT04908514
Start: 2021-05-07End: 2022-01-21Updated: 2025-03-11
A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough
CompletedNCT05392192
Start: 2022-04-07End: 2023-04-13Updated: 2025-02-28
Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome
WithdrawnNCT05599815
Start: 2023-01-31End: 2023-05-31Updated: 2024-04-17
A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)
CompletedNCT06685692
Start: 2024-11-04End: 2025-06-18Updated: 2026-06-03